Edesa Biotech

Share on: 
Website: Edesa Biotech

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company exploring new ways to treat dermatological and gastrointestinal diseases, including alternatives to topical steroids, using sPLA2 inhibitors as an approach to treating inflammation.

COVID-19: Edesa Biotech and Light Chain Bioscience of Switzerland have signed a licensing deal giving Edesa exclusive global rights for two biologic candidates that have the potential to treat COVID-19 patients with lung injury and acute respiratory distress syndrome. 

Career Page(s):